These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32178745)

  • 21. Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin-Proteasome Pathways in Lewy Body Disease.
    Kon T; Lee S; Martinez-Valbuena I; Yoshida K; Tanikawa S; Lang AE; Kovacs GG
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-synuclein in Lewy body disease and Alzheimer's disease.
    Hashimoto M; Masliah E
    Brain Pathol; 1999 Oct; 9(4):707-20. PubMed ID: 10517509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.
    Rockenstein E; Hansen LA; Mallory M; Trojanowski JQ; Galasko D; Masliah E
    Brain Res; 2001 Sep; 914(1-2):48-56. PubMed ID: 11578596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling Lewy body disease with
    Jin Y; Li F; Li Z; Ikezu TC; O'Leary J; Selvaraj M; Zhu Y; Martens YA; Koga S; Santhakumar H; Li Y; Lu W; You Y; Lolo K; DeTure M; Beasley AI; Davis MD; McLean PJ; Ross OA; Kanekiyo T; Ikezu T; Caulfield T; Carr J; Wszolek ZK; Bu G; Dickson DW; Zhao N
    Sci Adv; 2024 Sep; 10(37):eadk3700. PubMed ID: 39259788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease.
    Barba L; Abu-Rumeileh S; Barthel H; Massa F; Foschi M; Bellomo G; Gaetani L; Thal DR; Parnetti L; Otto M
    Brain; 2024 Oct; 147(10):3325-3343. PubMed ID: 38991041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of dementia with Lewy bodies: what are we missing?
    Meeus B; Theuns J; Van Broeckhoven C
    Arch Neurol; 2012 Sep; 69(9):1113-8. PubMed ID: 22635379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.
    Beyer K; Domingo-Sábat M; Lao JI; Carrato C; Ferrer I; Ariza A
    Neurogenetics; 2008 Feb; 9(1):15-23. PubMed ID: 17955272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
    Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Forrest SL; Crockford DR; Sizemova A; McCann H; Shepherd CE; McGeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; McGinley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM
    Neurology; 2019 May; 92(21):e2472-e2482. PubMed ID: 31019099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease.
    Koga S; Li F; Zhao N; Roemer SF; Ferman TJ; Wernick AI; Walton RL; Faroqi AH; Graff-Radford NR; Cheshire WP; Ross OA; Dickson DW
    Brain Pathol; 2020 Jul; 30(4):766-778. PubMed ID: 32232888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-Type Ca
    Xu J; Kawahata I; Izumi H; Fukunaga K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
    Beyer K; Domingo-Sàbat M; Humbert J; Carrato C; Ferrer I; Ariza A
    Neurogenetics; 2008 Jul; 9(3):163-72. PubMed ID: 18335262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular vesicle microRNA-mediated transcriptional regulation may contribute to dementia with Lewy bodies molecular pathology.
    Isik FB; Knight HM; Rajkumar AP
    Acta Neuropsychiatr; 2024 Feb; 36(1):29-38. PubMed ID: 37339939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
    Lutz MW; Saul R; Linnertz C; Glenn OC; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2015 Oct; 11(10):1133-43. PubMed ID: 26079410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinflammation in Lewy body dementia.
    Surendranathan A; Rowe JB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1398-406. PubMed ID: 26493111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.